Advertisement
Advertisement
LUNG
Pulmonx Corporation Common Stock
2.04
USDSponsored
-0.01
-0.49%
Aug 07, 15:59 UTC -4
Closed
Pre-Market
2.04
0.00
-0.25%
LUNG Earnings Reports
Positive Surprise Ratio
LUNG beat 23 of 24 last estimates.
96%
Next Report
Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
$22.38M
/-$0.28
Implied change from Q2 26 (Revenue/ EPS)
-1.64%
/+16.67%
Implied change from Q3 25 (Revenue/ EPS)
+4.10%
/-17.65%
Pulmonx Corporation Common Stock earnings per share and revenue
On Jul 29, 2026, LUNG reported earnings of -0.24 USD per share (EPS) for Q2 26, beating the estimate of -0.28 USD, resulting in a 15.97% surprise. Revenue reached 22.76 million, compared to an expected 22.85 million, with a -0.40% difference. The market reacted with a +28.80% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 8 analysts forecast an EPS of -0.28 USD, with revenue projected to reach 22.38 million USD, implying an increase of 16.67% EPS, and decrease of -1.64% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enovis Corporation
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.86
Actual
$0.90
Surprise
+3.97%
Claritev Corporation
Report Date
Aug 07, 2026 For Q2 26
Estimate
-$4.21
Actual
-$3.49
Surprise
+17.12%
Evolent Health, Inc Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.02
Actual
$0.02
Surprise
+183.68%
Senseonics Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.63
Actual
-$0.63
Surprise
+1.13%
Health Catalyst, Inc Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.02
Actual
$0.04
Surprise
+45.45%
CareCloud, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.06
Actual
$0.06
Surprise
-7.12%
Outset Medical, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.74
Actual
-$0.80
Surprise
-7.87%
10x Genomics, Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.24
Actual
-$0.14
Surprise
+43.09%
iRhythm Holdings, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
$0.57
Surprise
+12,988.89%
Doximity, Inc.
Report Date
Aug 06, 2026 For Q1 27
Estimate
$0.31
Actual
$0.28
Surprise
-6.66%
FAQ
What were Pulmonx Corporation Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Pulmonx Corporation Common Stock reported EPS of -$0.24, beating estimates by 15.97%, and revenue of $22.76M, -0.4% below expectations.
How did the market react to Pulmonx Corporation Common Stock's Q2 2026 earnings?
The stock price moved up 28.8%, changed from $1.25 before the earnings release to $1.61 the day after.
When is Pulmonx Corporation Common Stock expected to report next?
The next earning report is scheduled for Nov 10, 2026.
What are the forecasts for Pulmonx Corporation Common Stock's next earnings report?
Based on 8
analysts, Pulmonx Corporation Common Stock is expected to report EPS of -$0.28 and revenue of $22.38M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement